Azithromycin and the microbiota of cystic fibrosis sputum

BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Microbiol
Autors principals: Acosta, Nicole, Thornton, Christina S., Surette, Michael G., Somayaji, Ranjani, Rossi, Laura, Rabin, Harvey R., Parkins, Michael D.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008652/
https://ncbi.nlm.nih.gov/pubmed/33784986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02159-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars